1. Home
  2. IDYA vs VTMX Comparison

IDYA vs VTMX Comparison

Compare IDYA & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • VTMX
  • Stock Information
  • Founded
  • IDYA 2015
  • VTMX 1998
  • Country
  • IDYA United States
  • VTMX Mexico
  • Employees
  • IDYA N/A
  • VTMX N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • VTMX
  • Sector
  • IDYA Health Care
  • VTMX
  • Exchange
  • IDYA Nasdaq
  • VTMX Nasdaq
  • Market Cap
  • IDYA 2.0B
  • VTMX 2.0B
  • IPO Year
  • IDYA 2019
  • VTMX 2023
  • Fundamental
  • Price
  • IDYA $17.05
  • VTMX $23.05
  • Analyst Decision
  • IDYA Strong Buy
  • VTMX Sell
  • Analyst Count
  • IDYA 13
  • VTMX 2
  • Target Price
  • IDYA $53.58
  • VTMX $27.50
  • AVG Volume (30 Days)
  • IDYA 887.8K
  • VTMX 209.2K
  • Earning Date
  • IDYA 05-06-2025
  • VTMX 04-24-2025
  • Dividend Yield
  • IDYA N/A
  • VTMX 3.07%
  • EPS Growth
  • IDYA N/A
  • VTMX N/A
  • EPS
  • IDYA N/A
  • VTMX 0.25
  • Revenue
  • IDYA $7,000,000.00
  • VTMX $252,327,122.00
  • Revenue This Year
  • IDYA $89.14
  • VTMX $22.81
  • Revenue Next Year
  • IDYA $291.34
  • VTMX $9.13
  • P/E Ratio
  • IDYA N/A
  • VTMX $8.73
  • Revenue Growth
  • IDYA N/A
  • VTMX 17.65
  • 52 Week Low
  • IDYA $16.88
  • VTMX $22.10
  • 52 Week High
  • IDYA $44.42
  • VTMX $41.44
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 31.80
  • VTMX 41.12
  • Support Level
  • IDYA $17.05
  • VTMX $22.67
  • Resistance Level
  • IDYA $18.90
  • VTMX $24.24
  • Average True Range (ATR)
  • IDYA 0.91
  • VTMX 0.72
  • MACD
  • IDYA 0.01
  • VTMX 0.05
  • Stochastic Oscillator
  • IDYA 6.27
  • VTMX 39.42

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is a real estate company dedicated to the development and leasing of industrial buildings and distribution centers in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenues is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: